Published in Cancer Weekly, January 5th, 2010
"Forty-nine patients were analyzed with respect to age, tumor location, pTN stage and local lymph node involvement. The level of PTP4A3 expression was determined immunohistochemically using mouse monoclonal anti- PTP4A3 antibody (monoclonal antibody 3B6. anti-human PTP4A3 from Attogen Biomedical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2010-01-05)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.